Quick Answer
Xenon Pharmaceuticals Inc. reported Common Stock Shares Outstanding of 80.01 million shares for the year ending 2025.
- Xenon Pharmaceuticals Inc. showed an increase of +4.7% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Xenon Pharmaceuticals Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2013 to 2025), Xenon Pharmaceuticals Inc.'s Common Stock Shares Outstanding has grown by 5,850.4%.
- Historical annual values: Fiscal year 2025: 80.01 million shares | Fiscal year 2024: 76.42 million shares | Fiscal year 2023: 75.37 million shares | Fiscal year 2022: 62.59 million shares | Fiscal year 2021: 51.63 million shares | Fiscal year 2020: 35.01 million shares | Fiscal year 2019: 28.14 million shares | Fiscal year 2018: 25.75 million shares | Fiscal year 2017: 18.00 million shares | Fiscal year 2016: 17.93 million shares | Fiscal year 2015: 14.39 million shares | Fiscal year 2014: 14.18 million shares | Fiscal year 2014: 14.18 million shares | Fiscal year 2013: 1.34 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: